Product information and technical data sheet for ColorMatrix™ TripleA™ additive technology, which reduces Acetaldehyde levels in PET packaging Mevopur™ Healthcare Functional Additives Mevopur™ Bio-based Polymer Solutions

We maintain data related to the environmental, health and safety of our products in our product stewardship database. Through this data, we create safety data sheets and customer certification statements for intended use and product safety improvements. You can be certain that Avient meets or exceeds the material safety data reporting requirements of your countr y or region

Safety Data Sheets Technical Data Sheets Browse our library of product data sheets containing technical descriptions and details.

Save and share the full molding guide as a PDF for future reference. Download PDF

Safety Data Sheets Technical Data Sheets Browse our library of product data sheets containing technical descriptions and details.

Product Selection Help Product Selection Help Technical Data Sheets TPE Knowledge Center Please see the GLS Technical Datasheet for suggested starting conditions for each TPE. Product Selection Help Product Selection Help Technical Data Sheets TPE Knowledge Center

Safety Data Sheets Technical Data Sheets Browse our library of product data sheets containing technical descriptions and details.

Safety Data Sheets Technical Data Sheets Browse our library of product data sheets containing technical descriptions and details.

Avient acquired the Clariant Color business on July 1, 2020 (the “Acquisition Date”). We are better together through: Keeping Safety First — PolyOne and Clariant are both ACC Responsible Care® companies, and nothing is more important than the health, safety and well-being of our people. Free cash flow conversion calculated as (EBITDA – Capex) / EBITDA H I G H F R E E C A S H F L OW C O N V E R S I O N Avient reflects 2021 estimated EBITDA of $580M and estimated CAPEX of $80M (excludes one-time synergy capture CAPEX of $20M) Source: Peer data per Bloomberg market data as of November 8, 2021 86 93 85 83 79 77 75 89 85 83 81 79 79 78 77 74 25 A vi e n t K W R P P G A V Y F U L R P M G C P F M C U N V R C E B N R H X L A S H E C L E M N H U N S C L A L B (10) Source: Peer data per Bloomberg market data as of November 8, 2021 Total Enterprise Value / 2021E EBITDA Our current valuation with updated guidance implies an EBITDA multiple that is below many of our specialty formulator peers.

Save and share the full guide as a PDF for future reference. Download PDF